Active infection or chronic infection requiring chronic suppressive antibiotics Active infection requiring treatment with antibiotics Patients must not have a serious intercurrent illness, including ongoing or active infection requiring parental antibiotics Active uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are not excluded Active infection or chronic infection requiring chronic suppressive antibiotics. Active infection requiring IV antibiotics at day of cycle Active infection requiring IV antibiotics within weeks of study dose No active infection requiring antibiotics Patients with active infection requiring antibiotics are not eligible (with the exception of uncomplicated UTI and uncomplicated respiratory tract infections) Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI]) Active infection requiring antibiotics Active infection requiring iv antibiotics at day of cycle Patients who are otherwise ineligible to receive the antibiotics in this study EXCLUSION - PROCUREMENT: Active infection requiring antibiotics The patient has any ongoing or active infection, including active tuberculosis; Note: a urinary tract infection controlled with oral antibiotics initiated at least days prior to study entry is acceptable Active, uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are eligible Active infection requiring IV antibiotics on Cycle , Day Patients with active infection will not be eligible, but may become eligible once infection has resolved and they are at least days from completion of antibiotics Patients should not have any evidence of active or uncontrolled infection requiring treatment with antibiotics Currently using antibiotics and/or anti fungal agent (however, topical antibiotics are permitted). =< days before first dose of protocol-indicated treatment:\r\n* Anti-cancer therapy with an approved or investigational agent (including chemotherapy, hormonal therapy, targeted therapy, immunotherapy, or biological therapy).\r\n* Radiosurgery or radiotherapy. (Note: A tumor lesion situated in a previously irradiated area is considered a measurable/target lesion only if subsequent disease progression has been documented in the lesion.)\r\n* Initiation of a new erythropoietin, darbepoietin, and/or bisphosphonate therapy.\r\n* Minor surgery. (Note: Placement of a vascular access device is not considered minor or major surgery.)\r\n* Serious or uncontrolled infection.\r\n* Infection requiring parenteral antibiotics. (Note: Patients with a non-serious infection under active treatment and controlled with oral antibiotics initiated at least days prior to initiation of protocol-indicated treatment are not excluded e.g. urinary tract infection controlled with oral antibiotics.)\r\n* Unexplained fever > . degree Celsius (C). Active infection requiring systemic antibiotics or antifungals within days prior to first dose of study drug; exception: tetracycline family antibiotics (tetracycline, doxycycline, minocycline) administered for the management of cetuximab-related rash may be continued per the investigators judgment Active infection requiring the use of systemic antibiotics Participant has an active infection requiring IV antibiotics Active infection requiring systemic antibiotics within weeks prior to cycle , day ; prophylactic short-term antibiotics will be allowed Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI]) Active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection) Within days before first dose of protocol-indicated treatment:\r\n* Active uncontrolled infection; patients with infection under active treatment and controlled with antibiotics initiated at least days prior to initiation of protocol-indicated treatment are not excluded (e.g. urinary tract infection controlled with antibiotics) Has an active infection requiring systemic therapy with IV antibiotics Presence of an serious illness, uncontrolled illness, or active infection requiring IV antibiotics. Active infection or chronic infection requiring chronic suppressive antibiotics Have active infection requiring antibiotics Has an active infection requiring systemic antibiotics within days of registration Patients should not be on antibiotics for any infection but post operative antibiotics are allowed if used prophylactically but should be completed prior to starting RT Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI]) Patients with active infection will not be eligible, but may become eligible once infection has resolved and at least days have relapsed after antibiotics use was completed Known HIV- or any active infection requiring IV antibiotics Has active, serious infection requiring systemic therapy. Patients may receive prophylactic antibiotics and antiviral therapy at the discretion of the treating physician. Active infection requiring IV antibiotics days before enrollment Patients should be free of active infection requiring antibiotics Active infection requiring systemic therapy with IV antibiotics Active infection or chronic infection requiring chronic suppressive antibiotics. Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals. Active infection requiring antibiotics Active clinically significant infection requiring antibiotics Active infection requiring antibiotics Active infection or chronic infection requiring chronic suppressive antibiotics. Treated with antibiotics for infection within one week prior to study entry. Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals. Serious active infection not controlled by antibiotics Subjects with an active infection requiring antibiotics or at an increased risk of latent infection that may affect safe study participation Subjects with active infection requiring IV antibiotics within weeks of study enrollment (day ) are excluded Active, uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are eligible Active infection-must be afebrile and off antibiotics Participants with an active infection requiring antibiotics are excluded (a positive screening urinalysis may be repeated) Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals Active, uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are eligible Uncontrolled infection requiring active treatment (systemic antibiotics, anti-virals, or anti-fungals) within days Any active infection not controlled by antibiotics Infection requiring systemic antibiotic therapy or other serious infection within days before study enrollment unless the patient is felt to have fully recovered and any antibiotics that are continued are either beta lactam antibiotics or are specifically allowed on study Active infection or chronic infection requiring chronic suppressive antibiotics Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI]) Patients with any unstable medical issue (including cardiac issues as above, active treatment for pulmonary embolism, cerebrovascular accident [CVA], renal or hepatic insufficiency, active infection/sepsis requiring IV antibiotics) Evidence of any active infection requiring hospitalization or IV antibiotics within weeks prior to study enrolment. Patients should be free of active infection requiring antibiotics (with the exception of an uncomplicated urinary tract infection [UTI]) Active infection, or chronic infection requiring chronic suppressive antibiotics. Active pulmonary infection not responsive to conventional antibiotics Any known HIV infection or AIDS or any concurrent infection requiring IV antibiotics Has an active infection requiring systemic antibiotics within days of registration Active infection or antibiotics within hours prior to study Active infection within the days prior to randomization requiring systemic antibiotics Presence of active infection within hours of treatment; patients with ongoing use of prophylactic antibiotics are eligible as long as there is no evidence of active infection and the antibiotic is not included on the list of prohibited medications Active infection requiring treatment with IV antibiotics or hospitalized for treatment of an active infection in wks prior to starting dose of AMG . Presence of acute active infection requiring antibiotics Serious active infection requiring i.v. antibiotics and/or hospitalization at study entry Patients with an active infection requiring antibiotics Patients should be free of active infection requiring antibiotics Uncontrolled infection requiring ongoing antibiotics Patients with active infection will not be eligible, but may become eligible once infection has resolved and they are at least days from completion of antibiotics Current severe, uncontrolled systemic disease including an ongoing, active infection requiring treatment with antibiotics Active infection involving IV antibiotics within weeks prior to CD Active infection involving IV antibiotics within weeks prior to CD Active clinically significant infection requiring antibiotics Patients should not have any evidence of active or uncontrolled infection requiring treatment with antibiotics Has an active infection requiring antibiotics Ongoing or active infection requiring parental antibiotics on Day Known active infection requiring antibiotics within days of the start of treatment (day ) Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI]) No active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection) Ongoing or active infection requiring IV antibiotics Active infection requiring antibiotics Has an active infection requiring systemic antibiotics. Active infection requiring antibiotics Ongoing or active infection requiring antibiotics; Has an active infection requiring systemic antibiotics Active infection requiring IV antibiotics Infection not controlled by antibiotics Active infection requiring antibiotics Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals. The Medical Monitor should be contacted for any uncertainties. Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals, or anti-fungals. Active infection requiring antibiotics Active infection requiring antibiotics Active infection requiring IV antibiotics within weeks prior to screening Active infection requiring iv antibiotics Presence of an acute infection requiring antibiotics within weeks of study entry or a chronic infection including but not limited to: urinary tract infection, HIV, viral hepatitis Has uncontrolled infection requiring systematic antibiotics Active infection requiring (IV) antibiotics within weeks of study enrollment Active infection requiring IV antibiotics Any infection requiring antibiotics within the past weeks. Serious infection requiring antibiotics Pneumonia requiring antibiotics at the time of study enrollment Patients with a previous or current line infection are ineligible until days after the completion of antibiotics Infection not controlled by antibiotics Active infection requiring antibiotics No use of antibiotics in the previous months; or current regular use of antibiotics Patients should be free of active infection requiring antibiotics A non?urologic bacterial infection requiring active treatment with antibiotics Patients with active and/or uncontrolled infections or who are still recovering from an infection\r\n* Actively febrile patients with uncertain etiology of febrile episode\r\n* All antibiotics should be completed at least week ( days) prior to collection\r\n* No recurrence of fever or other symptoms related to infection for at least week ( days) following completion of antibiotics\r\n* Note: Use of antibiotics for pre-operative prophylaxis is not an exclusion The participant has an active infection (requiring I.V antibiotics), including tuberculosis. Known active infection requiring antibiotics within days of initiation of study treatment, unless considered controlled in the opinion of the investigator